ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 31717 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 31717; 2) Community: the network communities that were significantly associated with the response to NSC 31717; 3) Molecule: the relationships between components within communities and NSC 31717; 4) MDR: the compounds that were significantly associated with the NSC 31717.

NSC Compound Enrichment Correlation
NSC 683256 Null 0.00706774869341639 -0.033834036
NSC 684569 Barbituric acid, 5-[3-(4-methoxyphenyl)- 2-propenylidene]-2-thio- 0.00706774869341639 -0.081400629
NSC 685272 D-Glucose, [4-[(4-chlorophenyl)methylene]-5-oxo- 2-imidazolidinylidene]hydrazone 0.00706774869341639 -0.10683756
NSC 690271 ANTINEOPLASTIC-690271 0.00706774869341639 0.19037557
NSC 699666 Null 0.00706774869341639 -0.0053558317
NSC 700203 Null 0.00706774869341639 -0.00044072434
NSC 702015 1H-Indole-2-carboxylic acid, 2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl ester, (11aS)- 0.00706774869341639 0.15764805
NSC 705874 Null 0.00706774869341639 -0.19462633
NSC 709969 Null 0.00706774869341639 -0.028110042
NSC 709971 7H-Thieno[3',4':3,4]cyclopent[1,2-d]oxazol-7-one, 4,6-dibromo-1,2,3a,7a-tetrahydro-2-thioxo-, CIS- 0.00706774869341639 -0.027432985
Total:119  Current:20    [First] [Prev] [Next] [Last]